We are live on ! Find out more
CGH

Crossmark Global Holdings Portfolio holdings

AUM $7.71B
1-Year Est. Return 37.66%
This Fund
S&P 500
This Quarter Est. Return
+10.05%
1 Year Est. Return
+37.66%
3 Year Est. Return
+112.26%
5 Year Est. Return
+139.33%
10 Year Est. Return
AUM
$4.6B
AUM Growth
+$336M
Cap. Flow
-$52.5M
Cap. Flow %
-1.14%
Top 10 Hldgs %
16.11%
Holding
1,512
New
112
Increased
601
Reduced
632
Closed
144

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$14.7M
2
HMC icon
Honda
HMC
+$12.4M
3
ERIC icon
Ericsson
ERIC
+$12.2M
4
CCI icon
Crown Castle
CCI
+$10.7M
5
PG icon
Procter & Gamble
PG
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 26.02%
2 Financials 14.3%
3 Consumer Discretionary 12.58%
4 Healthcare 11.18%
5 Industrials 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBNY
651
DELISTED
Signature Bank
SBNY
$938K 0.02%
2,900
-1,396
-32% -$435K
HCA icon
652
HCA Healthcare
HCA
$89.5B
$937K 0.02%
3,648
-170
-4% -$41.6K
PEN icon
653
Penumbra
PEN
$12.8B
$934K 0.02%
3,252
-840
-21% -$222K
INGR icon
654
Ingredion
INGR
$6.58B
$929K 0.02%
9,612
+2,580
+37% +$248K
SXT icon
655
Sensient Technologies
SXT
$5.53B
$922K 0.02%
9,218
+6,100
+196% +$593K
UDR icon
656
UDR
UDR
$12.3B
$921K 0.02%
15,346
WAB icon
657
Wabtec
WAB
$49.3B
$906K 0.02%
9,837
-8,650
-47% -$793K
EMN icon
658
Eastman Chemical
EMN
$8.42B
$902K 0.02%
7,456
-740
-9% -$82.3K
BBD icon
659
Banco Bradesco
BBD
$36.7B
$901K 0.02%
289,936
-220,660
-43% -$730K
HBAN icon
660
Huntington Bancshares
HBAN
$35.5B
$901K 0.02%
58,406
-28,082
-32% -$443K
TNDM icon
661
Tandem Diabetes Care
TNDM
$1.56B
$896K 0.02%
5,950
+4,210
+242% +$568K
IGOV icon
662
iShares International Treasury Bond ETF
IGOV
$1.54B
$894K 0.02%
17,775
AA icon
663
Alcoa
AA
$13.2B
$893K 0.02%
+14,980
New +$751K
CE icon
664
Celanese
CE
$4.82B
$891K 0.02%
5,299
-210
-4% -$34.2K
BAH icon
665
Booz Allen Hamilton
BAH
$9.15B
$890K 0.02%
+10,500
New +$886K
HALO icon
666
Halozyme
HALO
$12.2B
$888K 0.02%
22,076
+1,760
+9% +$65.7K
J icon
667
Jacobs Solutions
J
$17B
$886K 0.02%
7,694
-1,547
-17% -$179K
ACM icon
668
Aecom
ACM
$9.75B
$885K 0.02%
11,437
-1,330
-10% -$93.4K
VTR icon
669
Ventas
VTR
$47.9B
$881K 0.02%
17,236
-2,480
-13% -$130K
MTB icon
670
M&T Bank
MTB
$36.2B
$878K 0.02%
5,719
-3,095
-35% -$475K
KMX icon
671
CarMax
KMX
$8.26B
$877K 0.02%
6,733
-2,270
-25% -$318K
CLF icon
672
Cleveland-Cliffs
CLF
$6.99B
$873K 0.02%
40,086
-9,710
-19% -$209K
OLED icon
673
Universal Display
OLED
$4.19B
$871K 0.02%
5,276
+1,310
+33% +$216K
AFG icon
674
American Financial Group
AFG
$12.1B
$869K 0.02%
6,327
+260
+4% +$35.7K
BRKR icon
675
Bruker
BRKR
$8.14B
$867K 0.02%
+10,329
New +$828K

Similar funds

Crossmark Global Holdings's Q4 2021 Portfolio in Review

As of Q4 2021, Crossmark Global Holdings held 1,512 positions worth $4.6B, up 7.9% from $4.27B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Crossmark Global Holdings's Q4 2021 filing shows 112 new, 601 increased, 632 reduced and 144 closed positions. Its largest new stake was Southern Company Series 2020A 4.95% Junior Subordinated Notes due Jan 30 2080: 252,015 shares worth $6.83M. The largest sale was Intuitive Surgical, an estimated $25.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Crossmark Global Holdings's largest Q4 2021 buy was Southern Company Series 2020A 4.95% Junior Subordinated Notes due Jan 30 2080: 252,015 shares worth $6.83M.
  • Crossmark Global Holdings added most to Cigna in Q4 2021, an estimated $14.7M increase.
  • Crossmark Global Holdings's biggest Q4 2021 reduction was Intuitive Surgical, cutting an estimated $25.8M.
  • Crossmark Global Holdings fully exited Coca-Cola Femsa in Q4 2021, selling an estimated $8.81M.
  • Crossmark Global Holdings's ten largest holdings make up 16% of its $4.6B portfolio in Q4 2021.
  • Crossmark Global Holdings opened 112 new positions and closed 144 in Q4 2021.
  • Crossmark Global Holdings's portfolio value rose 7.9% quarter-over-quarter to $4.6B.

Based on Crossmark Global Holdings's 13F filing for Q4 2021, filed 10 Jan 2022.